These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13139438)

  • 21. The protective effect of monovalent Asian-strain vaccine against Asian influenza.
    CULVER JO; NITZ RE; LENNETTE EH
    J Am Med Assoc; 1957 Dec; 165(17):2174-7. PubMed ID: 13480872
    [No Abstract]   [Full Text] [Related]  

  • 22. Problems of allocation and distribution of influenza vaccines.
    DAVIS DJ
    Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():168-70. PubMed ID: 13720155
    [No Abstract]   [Full Text] [Related]  

  • 23. Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial.
    HOWELLS CH; TYLER LE
    Lancet; 1961 Dec; 2(7218):1428-32. PubMed ID: 14449407
    [No Abstract]   [Full Text] [Related]  

  • 24. Inactivated influenza virus vaccines. Past, present, and future.
    DAVENPORT FM
    Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():146-56. PubMed ID: 13719955
    [No Abstract]   [Full Text] [Related]  

  • 25. Serological and prophylactic trials of Asian influenza vaccines in Sweden, 1957.
    HELLER L; KORLOF B; MORNER J; ZETTERBERG B
    Bull World Health Organ; 1959; 20(2-3):377-400. PubMed ID: 13651920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.
    HENNESSY AV; DAVENPORT FM
    Public Health Rep (1896); 1961 May; 76(5):411-9. PubMed ID: 13713365
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 28. An inactivated subvirion influenza A (H5N1) vaccine.
    Johansson BE; Brett IC
    N Engl J Med; 2006 Jun; 354(25):2724-5; author reply 2724-5. PubMed ID: 16790710
    [No Abstract]   [Full Text] [Related]  

  • 29. Serological responses and clinical reactions to influenza virus vaccines.
    HIMMELWEIT F
    Br Med J; 1960 Dec; 2(5214):1690-4. PubMed ID: 13714414
    [No Abstract]   [Full Text] [Related]  

  • 30. The serologic response in children to Asian influenza-virus vaccine.
    BATSON R; SANDERS R
    Pediatrics; 1960 Jun; 25():952-5. PubMed ID: 13797531
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serological response of subjects vaccinated with a single dose of Asian influenza A vaccine].
    PICCIOTTO L
    Riv Ist Sieroter Ital; 1958; 33(1):80-3. PubMed ID: 13528690
    [No Abstract]   [Full Text] [Related]  

  • 32. [Which influenza vaccination is the best - with whole virus, split vaccine or subunit vaccines?].
    Klenk HD; Stickl H
    Med Welt; 1981 Jun; 32(25):1008-9. PubMed ID: 7278577
    [No Abstract]   [Full Text] [Related]  

  • 33. Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season.
    Eick-Cost AA; Hu Z; Cooper MJ; Sanchez JL; Radin JM; Hawksworth AW; Brice GT; Lloyd LV; Tastad KJ; Zorich SC; MacIntosh VH
    MSMR; 2013 Mar; 20(3):15-6. PubMed ID: 23550929
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactions following use of influenza vaccine (Asian strain) in adults.
    SADUSK JF; NESCHE G
    Mod Hosp; 1957 Nov; 89(5):88 passim. PubMed ID: 13477206
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies in egg white antigen content of influenza virus vaccines.
    CHAO IT; SIEGEL BB; GROLNICK M
    J Allergy; 1960; 31():543-9. PubMed ID: 13692367
    [No Abstract]   [Full Text] [Related]  

  • 36. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variables influencing the preparation of influenza vaccines with formaldehyde.
    POLLEY JR
    Can J Microbiol; 1959 Apr; 5(2):237-44. PubMed ID: 13638900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preparation and use of inactive influenza vaccine].
    Bull World Health Organ; 1966; 35(6):945-7. PubMed ID: 5298043
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic bronchitis in industry; an account of a trial of H. influenzae vaccine.
    BROWN HM; WILSON RN
    Br Med J; 1959 Jan; 1(5117):263-7. PubMed ID: 13618613
    [No Abstract]   [Full Text] [Related]  

  • 40. How can we develop universal H5N1 vaccines.
    Tan Y; He F; Kwang J
    Immunotherapy; 2015; 7(7):713-6. PubMed ID: 26250411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.